Soligenix Stock Ten Year Return
| SNGX Stock | USD 1.55 0.04 2.65% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Soligenix's long-term financial health and intrinsic value.
Soligenix | Ten Year Return | Build AI portfolio with Soligenix Stock |
Soligenix Company Ten Year Return Analysis
Soligenix's Ten Year Return shows the total annualized return generated from holding a fund for the last 10 years and represents fund's capital appreciation, including dividends losses and capital gains distributions. This return indicator is considered by many investors to be the ultimate measures of fund performance and can reflect the overall performance of the market or market segment it invests in.
More About Ten Year Return | All Equity Analysis
Ten Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Soligenix Ten Year Return Driver Correlations
Understanding the fundamental principles of building solid financial models for Soligenix is extremely important. It helps to project a fair market value of Soligenix Stock properly, considering its historical fundamentals such as Ten Year Return. Since Soligenix's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Soligenix's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Soligenix's interrelated accounts and indicators.
Click cells to compare fundamentals
Although Ten Year Fund Return indicator can give a sense of overall fund long-term potential, it is recommended to compare funds performances against other similar funds or market benchmarks for the same 10-year interval.
| Competition |
Soligenix Return On Tangible Assets
Return On Tangible Assets |
|
Based on the latest financial disclosure, Soligenix has a Ten Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Soligenix Ten Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Soligenix's direct or indirect competition against its Ten Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Soligenix could also be used in its relative valuation, which is a method of valuing Soligenix by comparing valuation metrics of similar companies.Soligenix is currently under evaluation in ten year return category among its peers.
Soligenix Fundamentals
| Return On Equity | -3.91 | ||||
| Return On Asset | -0.91 | ||||
| Current Valuation | 6.03 M | ||||
| Shares Outstanding | 8.37 M | ||||
| Shares Owned By Insiders | 0.18 % | ||||
| Shares Owned By Institutions | 2.26 % | ||||
| Number Of Shares Shorted | 1.03 M | ||||
| Price To Earning | (1.67) X | ||||
| Price To Book | 5.86 X | ||||
| Price To Sales | 3,875 X | ||||
| Revenue | 119.37 K | ||||
| EBITDA | (8.64 M) | ||||
| Net Income | (8.27 M) | ||||
| Cash And Equivalents | 20.16 M | ||||
| Cash Per Share | 0.47 X | ||||
| Total Debt | 1.48 M | ||||
| Debt To Equity | 2.44 % | ||||
| Current Ratio | 2.36 X | ||||
| Book Value Per Share | 0.52 X | ||||
| Cash Flow From Operations | (8.4 M) | ||||
| Short Ratio | 0.40 X | ||||
| Earnings Per Share | (3.06) X | ||||
| Price To Earnings To Growth | (1.52) X | ||||
| Target Price | 17.5 | ||||
| Number Of Employees | 14 | ||||
| Beta | 1.96 | ||||
| Market Capitalization | 12.64 M | ||||
| Total Asset | 8.97 M | ||||
| Retained Earnings | (233.97 M) | ||||
| Working Capital | 3.98 M | ||||
| Current Asset | 7.15 M | ||||
| Current Liabilities | 7.41 M | ||||
| Net Asset | 8.97 M |
About Soligenix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Soligenix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Soligenix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Soligenix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Soligenix Stock Analysis
When running Soligenix's price analysis, check to measure Soligenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Soligenix is operating at the current time. Most of Soligenix's value examination focuses on studying past and present price action to predict the probability of Soligenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Soligenix's price. Additionally, you may evaluate how the addition of Soligenix to your portfolios can decrease your overall portfolio volatility.